Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/28/2012US20120164227 New granulating process and thus prepared granulate
06/28/2012US20120164226 Compositions and Methods for Improving Prognosis of a Human with Subarachnoid Hemorrhage
06/28/2012US20120164222 Novel compounds and compositions and methods of use
06/28/2012US20120164221 Combinations of hmg-coa reductase inhibitors and nicotinic acid compounds and methods for treating hyperlipidemia once a day at night
06/28/2012US20120164220 Encased Tamper Resistant Controlled Release Dosage Forms
06/28/2012US20120164218 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
06/28/2012US20120164216 Pharmaceutical composition of duloxetine or pharmaceutically
06/28/2012US20120164215 Topical co-enzyme q10 formulations and methods of use
06/28/2012US20120164213 Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application
06/28/2012US20120164211 Compositions and methods for treating lymphoma
06/28/2012US20120164210 Photodynamic therapeutic agent having cell-specific active accumulation properties
06/28/2012US20120164209 Abuse resistant drugs, method of use and method of making
06/28/2012US20120164208 Chitosan hydrogel derivatives as a coating agent with broad spectrum of antimicrobial activities
06/28/2012US20120164207 Degradable networks for sustained release and controlled release depot drug delivery applications
06/28/2012US20120164193 Extended-release formulation for reducing the frequency of urination and method of use thereof
06/28/2012US20120164192 Delayed release formulation for reducing the frequency of urination and method of use thereof
06/28/2012US20120164191 Transmucosal delivery devices with enhanced uptake
06/28/2012US20120164190 Nanoparticle isoflavone compositions & methods of making and using the same
06/28/2012US20120164188 Paliperidone or a pharmaceutically acceptable salt thereof substantially free of impurities
06/28/2012US20120164183 Method for detection and treatment of aneurysms
06/28/2012US20120164171 Antiviral Activity of Bovine Type III Interferon Against Foot-and-Mouth Disease Virus
06/28/2012US20120164154 Method for increasing insulin sensitivity and for treating and preventing type 2 diabetes
06/28/2012US20120164151 Methods for Treatment of Muscular Dystrophy
06/28/2012US20120164149 Use of inhibitors of leukotriene b4 receptor blt2 for treating asthma
06/28/2012US20120164148 Compositions Containing JARID1B Inhibitors and Methods for Treating Cancer
06/28/2012US20120164145 H. pylori lipopolysaccharide outer core epitope
06/28/2012US20120164142 Compositions comprising natriuretic peptides and methods of use thereof
06/28/2012US20120164139 Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders
06/28/2012US20120164136 Compositions and Methods for Treatment of Cancer by Disrupting the LH/LHR Signaling Pathway
06/28/2012US20120164134 Sugar-free chewable supplement
06/28/2012US20120164128 Means and methods for counteracting polyq expansion disorders
06/28/2012US20120164124 Phage-associated lytic enzymes for treatment of bacillus anthracis and related conditions
06/28/2012US20120164122 Phytoestrogenic formulations for alleviation or prevention of neurodegenerative diseases
06/28/2012US20120164120 Novel monascuspurpurones, preparation process thereof, and uses of the monascuspurpurones
06/28/2012US20120164108 Virus strains
06/28/2012US20120164104 Composition and Methods of Treating Viral Infections and Viral Induced Tumors
06/28/2012US20120164103 Compounds and Methods for the Treatment or Prevention of Flavivirus Infections
06/28/2012US20120164102 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
06/28/2012US20120164101 Gm-csf and interleukin-21 conjugates and uses thereof in the modulation of immune response and treatment of cancer
06/28/2012US20120164080 Methods of treatment for esophageal inflammation
06/28/2012US20120164078 Methods of using sustained release aminopyridine compositions
06/28/2012US20120164076 Methods of treatment using thymus-derived compositions
06/28/2012US20120164075 Endoxifen methods and compositions in the treatment of mammalian diseases
06/28/2012US20120164074 Methods of diagnosing, preventing and treating cancer metastasis
06/28/2012US20120164072 Nano-sized particles comprising multi-headed amphiphiles for targeted drug delivery
06/28/2012US20120164070 Benzothiazole and benzooxazole derivatives and methods of use
06/28/2012US20120164067 Methods of preventing or treating pain using anti-ngf antibodies that selectively inhibit the association of ngf with trka, without affecting the association of ngf with p75
06/28/2012US20120164065 Method and composition for treating cancer
06/28/2012DE102010064245A1 Use of macrocyclic lactones used in controlling endoparasitic filariae and gastrointestinal nematodes, particularly used in controlling heartworm
06/28/2012DE102010063974A1 Preparing a radioactive fluorine substituted (1,2,4)oxadiazole compound, useful as radiodiagnostic to diagonize e.g. neurological and psychiatric disorders, comprises reacting a (1,2,4)oxadiazole compound with a radioactive fluorine
06/28/2012DE102010056443A1 New chlorin derivative useful as photosensitizer in photodynamic tumor therapy
06/28/2012DE102010055771A1 Composition useful as a medicament for therapeutic, prophylactic, cosmetic or health-promoting functions in e.g. humans comprises chlorite and polyvalent alcohol in aqueous or alcoholic-aqueous chlorine dioxide-containing solution
06/28/2012CA2845524A1 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
06/28/2012CA2822923A1 A process for the preparation of lapatinib and its ditosylate salt
06/28/2012CA2822898A1 Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders
06/28/2012CA2822842A1 Faah inhibitors
06/28/2012CA2822805A1 Novel imidazole-2-benzamide compounds useful for the treatment of osteoarthritis
06/28/2012CA2822795A1 Novel preparation of an enteric release system
06/28/2012CA2822790A1 Encased tamper resistant controlled release dosage forms
06/28/2012CA2822789A1 Substituted pyridines as sodium channel blockers
06/28/2012CA2822787A1 Novel substituted isoquinoline derivative
06/28/2012CA2822769A1 Tamper resistant solid oral dosage forms
06/28/2012CA2822767A1 Polymorphs of 3-chloro-4[(2r)-2-(4-chlorophenyl)-4-[(1r)-1-(4-cyanophenyl)ethyl]-1-piperazinyl]-benzonitrile, pharmaceutical compositions and method of use comprising said polymorphs, and a process for preparing them
06/28/2012CA2822758A1 Optically active diazabicyclooctane derivative and process for preparing the same
06/28/2012CA2822745A1 A composition comprising at least to compounds which induces indolamine 2,3-dioxygenase (ido), for the treatment of an autoimmune disorder or suffering from immune rejection of organs
06/28/2012CA2822725A1 Modulators and methods for the treatment of rosacea
06/28/2012CA2822701A1 Novel pharmaceutical composition
06/28/2012CA2822694A1 Purified cardiogenin isomer and related methods
06/28/2012CA2822672A1 Methods for treating copd
06/28/2012CA2822639A1 Methods for treating systemic lupus erythematosus using hiv protease inhibitors
06/28/2012CA2822617A1 Methods for treating metabolic disorders and obesity with gip and glp-1 receptor-active glucagon-based peptides
06/28/2012CA2822565A1 Bi-heteroaryl compounds as vps34 inhibitors
06/28/2012CA2822553A1 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
06/28/2012CA2822547A1 Dermatological foams obtained from a gel or suspension containing benzoyl peroxide
06/28/2012CA2822546A1 Dermatological foams obtained from a gel or suspension containing adapalene
06/28/2012CA2822539A1 Dermatological foams obtained from a gel or suspension containing a combination of adapalene and benzoyl peroxide
06/28/2012CA2822493A1 Selective glycosidase inhibitors and uses thereof
06/28/2012CA2822453A1 Novel morphinans useful as analgesics
06/28/2012CA2822432A1 Bicyclic pkm2 activators
06/28/2012CA2822410A1 Novel platinum-carbene complexes and use thereof as medicaments
06/28/2012CA2822378A1 Compounds and their use as bace inhibitors
06/28/2012CA2822360A1 Ingenol-3-acylates i
06/28/2012CA2822357A1 Hepatitis c inhibitors and uses thereof
06/28/2012CA2822347A1 Sanglifehrin derivatives and methods for their production
06/28/2012CA2822320A1 Composition for the treatment of skin conditions
06/28/2012CA2822312A1 3-acyl-ingenols ii
06/28/2012CA2822310A1 Ingenol-3-acylates iii and ingenol-3-carbamates
06/28/2012CA2822265A1 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
06/28/2012CA2822263A1 Methods and compositions for preventing and treating osteoarthritis
06/28/2012CA2822213A1 Combination and composition for treating obesity
06/28/2012CA2822166A1 Indazolyl triazole derivatives as irak inhibitors
06/28/2012CA2822080A1 Ectoparasiticidal active substance combinations
06/28/2012CA2822070A1 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/28/2012CA2822037A1 Methods for treating hcv
06/28/2012CA2822027A1 Halogenated biphenols as antibacterial agents
06/28/2012CA2822017A1 Glucagon receptor modulators
06/28/2012CA2821937A1 Bicyclo[3.2.1]octyl amide derivatives and uses of same
06/28/2012CA2821807A1 Methods and compositions suitable for managing blood glucose in animals
06/28/2012CA2821638A1 Conjugated 3-(indolyl)- and 3-(azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment
06/28/2012CA2821546A1 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives